These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem.
    Author: Van der Auwera P, Ernst F, Grenier P, Glupczynski Y, Husson M, Klastersky J.
    Journal: J Antimicrob Chemother; 1987 Aug; 20(2):179-89. PubMed ID: 3478328.
    Abstract:
    The minimum inhibitory concentrations (MICs) of two new penems, CGP 31608 and FCE 22101 were evaluated against 993 aerobic Gram-positive and Gram-negative bacteria and compared with imipenem. FCE 22101 was usually two to eight-fold more active than CGP 31608 except for Pseudomonas aeruginosa against which FCE 22101 was inactive. Both new penems were less active than imipenem. MBCs were equal to 1-2 X MICs. The effects of inocula, cations and serum were minimal. The MICs and MBCs were higher at pH 8 than at pH 6 or 7. Synergy between the new penems and amikacin was detected in 30% of the strains studied. Antagonism occurred with some Gram-positive bacteria.
    [Abstract] [Full Text] [Related] [New Search]